CD163 and metabolic dysfunction-associated steatotic liver disease: The quantification of mIF revealed an elevation in iNOS, a marker associated with M1 macrophages, and a reduction in CD163, a marker for M2 macrophages, within the livers of individuals afflicted with NAFLD or NASH, as opposed to those with non‐steatotic livers (Figure 12A).